drugset
drugset / Trial / NCT00543218

PTH Comparison in Post Menopausal Women

NCT00543218 ↗

Phase 3 Completed 63 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

Compare in postmenopausal women with established osteoporosis the effect of treatment with teriparatide 20 micrograms/day subcutaneous with the effect of salmon calcitonin 100 IU/day subcutaneous on change in lumbar spine BMD.

Timeline

Start
2002-12
Primary completion
—
Completion
2004-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcitonin Protein / enzyme biologic 100 iu Subcutaneous
Comparator Teriparatide Protein / enzyme biologic 20 ug Subcutaneous

Indications

postmenopausal osteoporosis